Download Files:

GSK2334470

SKU HY-14981-10 mg Category Reference compound Tags Cancer, PDK-1, PI3K/Akt/mTOR

$63 – $550

Size

5 mg 10mM/1mL 10 mg 50 mg 100 mg

Clear

Products Details

Product Description

– GSK2334470 is a highly specific and potent inhibitor of PDK1 with an IC50 of 10 nM.

Web ID

– HY-14981

Storage Temperature

– -20°C, 3 years; 4°C, 2 years (Powder)

Shipping

– Room Temperature

Applications

– Cancer-Kinase/protease

Molecular Formula

– C25H34N8O

References

– [1]Najafov A, et al. Characterization of GSK2334470, a novel and highly specific inhibitor of PDK1. Biochem J.?2011 Jan 15;433(2):357-69.|[2]Qi L, et al. PDK1-mTOR signaling pathway inhibitors reduce cell proliferation in MK2206 resistant neuroblastoma cells. Cancer Cell Int.?2015 Sep 29;15:91.|[3]Scortegagna M, et al. Genetic inactivation or pharmacological inhibition of Pdk1 delays development and inhibits metastasis of Braf(V600E)::Pten(-/-) melanoma. Oncogene. 2014 Aug 21;33(34):4330-9.

CAS Number

– 1227911-45-6

Molecular Weight

– 462.59

Compound Purity

– 99.78

SMILES

– O=C([C@@H]1CN(C2=NC(NC)=NC(C3=CC4=C(C=C3)C(N)=NN4)=C2)[C@H](C)CC1)NC5CCCCC5

Clinical Information

– No Development Reported

Research Area

– Cancer

Solubility

– DMSO : ≥ 50 mg/mL

Target

– PDK-1

Pathway

– PI3K/Akt/mTOR

Product type

– Reference compound

Booklet

Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.